000518 *ST四環生物
按盤價 
2.890 +0.010 (+0.347%)
2.890 +0.010 (+0.347%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.439 | -10.503 | -25.777 | -14.490 | -8.389 |
| 總資產報酬率 ROA (%) | -2.325 | -6.989 | -17.909 | -10.760 | -6.347 |
| 投入資產回報率 ROIC (%) | -2.894 | -8.835 | -22.132 | -12.951 | -7.593 | 邊際利潤分析 |
| 銷售毛利率 (%) | 19.132 | 37.302 | 62.682 | 69.761 | 71.035 |
| 營業利潤率 (%) | -15.408 | -11.767 | -38.747 | -32.517 | -20.047 |
| 息稅前利潤/營業總收入 (%) | -14.881 | -11.389 | -54.869 | -32.725 | -19.249 |
| 淨利潤/營業總收入 (%) | -15.132 | -11.502 | -55.920 | -34.158 | -19.723 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.993 | 80.850 | 33.030 | 65.806 | 76.611 |
| 價值變動淨收益/利潤總額(%) | 0.082 | -8.616 | -0.441 | -2.175 | 0.487 |
| 營業外收支淨額/利潤總額(%) | 0.000 | 0.976 | 30.665 | 3.618 | -1.028 | 償債能力分析 |
| 流動比率 (X) | 3.150 | 3.627 | 3.339 | 4.311 | 4.860 |
| 速動比率 (X) | 1.503 | 1.563 | 0.648 | 0.854 | 1.343 |
| 資產負債率 (%) | 27.573 | 27.261 | 29.684 | 22.421 | 19.589 |
| 帶息債務/全部投入資本 (%) | 10.080 | 6.940 | 9.562 | 6.037 | 5.202 |
| 股東權益/帶息債務 (%) | 818.841 | 1,235.395 | 865.056 | 1,464.978 | 1,734.084 |
| 股東權益/負債合計 (%) | 244.688 | 248.456 | 220.694 | 325.050 | 385.412 |
| 利息保障倍數 (X) | -28.235 | -23.023 | -54.078 | -32.322 | -32.414 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 79.326 | 70.359 | 120.182 | 129.931 | 146.201 |
| 存貨周轉天數 (天) | 266.597 | 482.466 | 1,821.128 | 2,066.560 | 1,930.987 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/04/2026 11:44 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
